Lighthouse Investment Partners’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-850,000
Closed -$8.88M 803
2025
Q2
$8.88M Buy
850,000
+400,000
+89% +$4.15M 0.33% 73
2025
Q1
$4.6M Buy
450,000
+150,000
+50% +$1.51M 0.19% 165
2024
Q4
$3.04M Buy
+300,000
New +$2.99M 0.1% 232

Other funds holding OACC

Lighthouse Investment Partners's OACC Position: Q3 2025 in Review

Lighthouse Investment Partners sold out of Oaktree Acquisition Corp III Life Sciences (OACC) in Q3 2025, closing a stake of 850,000 shares — an estimated $8.88M sold.

Lighthouse Investment Partners first reported a position in OACC in Q4 2024 and held it in 3 quarters. The position peaked at $8.88M in Q2 2025. 48 funds tracked by Wall St. Rank hold OACC as of Q3 2025.

  • Lighthouse Investment Partners reported no remaining Oaktree Acquisition Corp III Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Lighthouse Investment Partners sold 850,000 Oaktree Acquisition Corp III Life Sciences shares in Q3 2025, an estimated $8.88M.
  • Lighthouse Investment Partners first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and held it in 3 quarters.
  • Lighthouse Investment Partners's Oaktree Acquisition Corp III Life Sciences position peaked at $8.88M in Q2 2025.
  • 48 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2025.

Based on Lighthouse Investment Partners's 13F filing for Q3 2025, filed 14 Nov 2025.